ASSURED GUARANTY LTD

Financial Results

(1) See “— Non-GAAP Financial Measures” for a definition of the financial measures that were not determined in accordance with accounting principles generally accepted in the United States of America (GAAP), a reconciliation of the non-GAAP financial measure to the most directly comparable GAAP measure, if available, and for additional details.

(2) Relates to the effect of consolidating FG VIEs and CIVs.

(3) See “— Overview — Key Business Strategies — Capital Management” above for information on common share repurchases.

Condensed Consolidated Results of Operations

Condensed Consolidated Results of Operations

Second Quarter 2026 Compared with Second Quarter 2025

Net income attributable to AGL for second quarter 2026 was lower compared with the three-month period ended June 30, 2025 (second quarter 2025) primarily due to the following:

•foreign exchange losses on remeasurement of $2 million in second quarter 2026, compared with gains of $79 million in second quarter 2025, and

•lower equity in earnings of investees in second quarter 2026, primarily due to losses generated by the Company’s investment in a collateralized loan obligation (CLO) fund.

These decreases were partially offset by:

•a loss and LAE in second quarter 2026 of $4 million compared with a loss and LAE of $28 million in second quarter 2025.

Six Months 2026 Compared with Six Months 2025

Net income attributable to AGL for six months 2026 was lower compared with six months 2025 primarily due to the following:

•foreign exchange losses on remeasurement of $21 million in six months 2026, compared with gains of $116 million in six months 2025,

•a fair value gain on credit derivatives related to the resolution of the LBIE litigation of $103 million in six months 2025, and

•a decrease of $36 million in equity in earnings of investees in six months 2026, primarily due to losses generated by the Company’s investment in a CLO equity fund.

These decreases were partially offset by:

•a lower loss and LAE in six months 2026 of $21 million, compared with a loss and LAE of $68 million in six months 2025,

•a discrete tax benefit of $33 million in the first quarter of 2026 resulting from the enactment of the U.K. Finance Act 2026, which clarified that certain Bermuda pre-regime deferred taxes are excluded from covered taxes under the Pillar Two global minimum tax framework, and

•the increase of $21 million in performance fees (net of related expenses) due to the impact of the payout of carried interest from the sale of the underlying asset in a single-asset fund in the first quarter of 2026.

The Company’s effective tax rate reflects the proportion of income recognized by each of the Company’s operating subsidiaries in the jurisdiction in which they are taxed, with U.S. subsidiaries and foreign subsidiaries that have made an election to be a U.S. taxpayer taxed at the U.S. marginal corporate income tax rate of 21%, U.K. subsidiaries taxed at the U.K. marginal corporate tax rate of 25%, the French subsidiary taxed at the French marginal corporate tax rate of 25% and AG Re and Cedar Personnel Ltd. taxed at the Bermuda marginal corporate tax rate of 15% starting January 1, 2025. See Item 1. Financial Statements, Note 12. Income Taxes.

The following tables present pre-tax income by jurisdiction.

Pre-tax Income (Loss) by Tax Jurisdiction

Adjusted Operating Income

Adjusted operating income in second quarter 2026 was $55 million, compared with $50 million in second quarter 2025. The increase was primarily due to lower loss expense of $24 million primarily related to the U.S. and non-U.S. public finance sectors and the increase of $14 million in net earned premiums and credit derivative revenues in second quarter 2026, partially offset by the decreases of $14 million in equity in earnings of investees, $9 million in foreign exchange remeasurement gains related primarily to cash and lower other income due primarily to $6 million of interest received on late financial guaranty premiums in second quarter 2025. See “— Results of Operations — Reconciliation to GAAP” for the reconciliation of net income (loss) attributable to AGL to adjusted operating income (loss).

Adjusted operating income in six months 2026 was $170 million, compared with $212 million in six months 2025. The decrease was primarily due to a $103 million gain related to the resolution of the LBIE litigation in six months 2025, a decrease of $36 million in equity in earnings of investees in six months 2026 primarily due to losses generated by the Company’s investment in a CLO equity fund, and lower other income due to $15 million recognized in six months 2025 associated with the workout and purchase of bonds issued by a U.K. regulated utility to which the Company has insured exposure and interest received on late financial guaranty premiums. These decreases were offset in part by a $51 million decrease in loss expense in the public finance sector, a $33 million discrete tax benefit resulting from the enactment of the U.K. Finance Act 2026, and a $21 million increase in performance fees, net of related expenses, due to the impact of the payout of carried interest from the sale of the underlying asset in a single-asset fund in six months 2026. See “— Results of Operations — Reconciliation to GAAP” for the reconciliation of net income (loss) attributable to AGL to adjusted operating income (loss).

Book Value and ABV

Shareholders’ equity attributable to AGL as of June 30, 2026 decreased compared with December 31, 2025, primarily due to unrealized losses on the investment portfolio, share repurchases and dividends, partially offset by net income. Adjusted operating shareholders’ equity decreased primarily due to share repurchases and dividends, partially offset by adjusted operating income. ABV decreased primarily due to share repurchases, dividends and loss development, partially offset by adjusted operating income, GWP and the accretive effect of Assured Life Re Acquisition. See “— Non-GAAP Financial Measures” below for the reconciliation of shareholders’ equity attributable to AGL to adjusted operating shareholders' equity and ABV.

On a per share basis, shareholders’ equity attributable to AGL, adjusted operating shareholders’ equity and ABV increased as of June 30, 2026 compared with December 31, 2025, due, in part, to the accretive effect of the share repurchase program and Assured Life Re Acquisition. See “— Non-GAAP Financial Measures” for the reconciliation of shareholders’ equity attributable to AGL to adjusted operating shareholders’ equity and ABV.